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Association of SIX1/SIX6 locus 
polymorphisms with regional 
circumpapillary retinal nerve fibre 
layer thickness: The Nagahama 
study
Munemitsu Yoshikawa1, Kenji Yamashiro  1,2, Hideo Nakanishi1, Manabu Miyata  1, 
Masahiro Miyake1,3, Yoshikatsu Hosoda1, Yasuharu Tabara3, Fumihiko Matsuda3 ,  
Nagahisa Yoshimura1 & the Nagahama Study Group*
SIX1 and SIX6 are glaucoma susceptibility genes. Previous reports indicate that the single nucleotide 
polymorphism (SNP) rs33912345 in SIX6 is associated with inferior circumpapillary retinal nerve fibre 
layer (cpRNFL) thickness (cpRNFLT). Although the region of visual field defect in glaucoma patients 
is directly related to cpRNFL thinning, a detailed sector analysis has not been performed in genetic 
association studies. In the present study, we evaluated 26 tagging SNPs in the SIX1/SIX6 locus ±50 kb 
region in a population of 2,306 Japanese subjects with 4- and 32-sector cpRNFLT analysis. While no 
SNPs showed a significant association with cpRNFLT in the 4-sectored analysis, the finer 32-sector 
assessment clearly showed a significant association between rs33912345 in the SIX1/SIX6 locus with 
inferior cpRNFL thinning at 292.5–303.8° (β = −4.55, P = 3.0 × 10−5). Furthermore, the fine-sectored 
cpRNFLT analysis indicated that SIX1/SIX6 polymorphisms would affect cpRNFL thinning at 281.3–
303.8°, which corresponds to parafoveal scotoma in a visual field test of glaucoma patients.
Glaucoma is a complex vision-threatening disorder with a multifactorial aetiology that includes both genetic 
and environmental factors1–3, and it is one of the most prevalent causes of irreversible blindness worldwide4. To 
date, various glaucoma susceptibility genes have been identified by genome-wide association studies (GWAS)5–13. 
While the majority of associated genes have been characterized5–8, GWAS for glaucoma endophenotypes—such 
as vertical cup-to-disc ratio (VCDR)9, 10 and intraocular pressure (IOP)11–13—have also contributed to the discov-
ery of glaucoma susceptibility genes, indicative of endophenotype-specific genetic associations. Of the known 
glaucoma susceptibility genes, several have been shown to exhibit associations with race14, sex15, 16, and the loca-
tion of the visual field defect (VFD)17–20.
Although glaucomatous VFD generally occurs in the upper hemifield, early involvement of the inferior hem-
ifield and/or the paracentral VFD has been observed in certain subgroups with low-tension glaucoma or myopia, 
resulting in severely impaired quality of vision (QOV) from the initial stages of disease21–25. Therefore, the ability 
to predict the risk of these QOV-threatening VFD patterns using specific genetic associations to the locations of 
the VFD would be highly beneficial. However, current visual field testing is based on subjective patient responses 
and can be susceptible to various extraneous factors, such as cataract, dementia, concentration, and physical con-
ditions, thus preventing an accurate evaluation of the associations between susceptibility genes and VFD patterns.
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Recent advances in optical coherence tomography (OCT) have allowed ophthalmologists to perform quantita-
tive evaluations of circumpapillary retinal nerve fibre layer thickness (cpRNFLT), which represents glaucomatous 
optic neuropathy (GON) with high reproducibility and reliability. This morphological testing method generates 
objective data less influenced by the problems listed above26. The association between cpRNFLT and VFD pattern 
is highly correlative27–29, suggesting that cpRNFLT would be a better measure to evaluate the genetic contribution 
to GON endophenotype than visual field testing.
To date, genetic studies on cpRNFLT have shown consistent contributions of the single nucleotide polymor-
phisms (SNPs) rs33912345 and rs10483727 located within the SIX1/SIX6 loci to cpRNFL thinning in the superior 
and inferior sectors, but not in the temporal, nasal, and global sectors30–32. The significance of the SIX1/SIX6 locus 
in glaucoma was initially discovered by GWAS for VCDR and primary open-angle glaucoma (POAG), and sub-
sequent studies confirmed the association of polymorphisms in this region with glaucoma onset.9, 33, 34 According 
to previous GON structure-function correlations27–29, a finer cpRNFLT analysis with >4 sectors would be better 
suited to fully evaluate the risk of QOV-threatening VFD patterns. Therefore, the present study examined genetic 
associations of the SIX1/SIX6 locus with cpRNFLT using 4- and 32-sector analyses.
Results
Study population. Participants were excluded due to prior intraocular surgery (N = 125), axial length 
≥26 mm (N = 258), presence of other ocular disease (N = 64), and cpRNFL image quality (N = 54) as described 
in the Methods section. A total of 2,306 subjects passed the exclusion criteria and the participant demographics 
are shown in Table 1. The average age was 57.6 ± 13.6 years (mean ± SD; range, 34–80 years). Mean axial length of 
the right eye was 23.78 ± 1.04 mm (range, 16.46–25.99 mm). Two-thirds of the participants (68.9%) were females; 
however, this did not affect global cpRNFLT after the adjustment for age and axial length. The mean global cpRN-
FLT was 101.6 ± 12.0 μm, and 122.4 ± 20.0 μm, 132.1 ± 20.8 μm, 76.3 ± 13.9 μm, and 75.5 ± 14.3 μm in the supe-
rior, inferior, temporal, and nasal sectors, respectively.
Association of SIX1/SIX6 polymorphisms with regional cpRNFLT. Association of the 26 tagging 
SNPs along the 4 cpRNFLT sectors are shown in Table 2. Only rs12147345 showed a marginal association with 
cpRNFLT in the temporal region (β = 1.08; 95% confidential interval [CI], 0.26–1.90; P = 0.010). On the other 
hand, a finer assessment with 32 sectors found 5 additional SIX1/SIX6 SNPs, including rs33912345, to be sig-
nificantly or marginally associated with a cpRNFLT region, mostly in inferior sectors (Table 3). Among these 6 
SNPs, only rs148908311 showed a marginal association with cpRNFLT in the superior region, whereas the other 
5 SNPs showed significant or marginal associations with cpRNFLT in the inferior regions. The strongest and only 
significant association (P < 6.0 × 10−5; 0.05/26 SNPs/32 sectors) was observed between rs33912345 and cpRNFLT 
in the inferior region at 292.5–303.8° (β = −4.55; 95% CI, −2.42–−6.69), P = 3.0 × 10−5). For all SNPs that were 
significantly or marginally associated with regional cpRNFLTs, we confirmed identical effect directions of the 
genetic variances to the regional cpRNFLT as to the global cpRNFLT.
We observed that rs10483727—the only SIX1/SIX6 SNP previously associated with glaucoma susceptibility 
by GWAS—was in close linkage disequilibrium (LD) with rs33912345 (R-sq = 0.99 in the JPT 1000 genomes 
dataset). Although rs10483727 was not included in the tagging SNPs in the present study, the C risk allele of 
rs33912345 (corresponding to the T risk allele of rs10483727) resulted in both regional and global cpRNFL 
thinning.
Discussion
Our study used a tagging SNP approach to show that polymorphisms in the SIX1/SIX6 region was significantly 
associated with inferior cpRNFLT and marginally associated with superior cpRNFLT in a community-based 
Japanese cohort. These results were consistent with previous candidate SNP evaluations on rs3391234530–32. In 
addition, our findings suggest that the 32-sector region-based approach for cpRNFLT enables the detection of 
underpowered and undermined genetic associations in 4-sector analyses.
The importance of the SIX1/SIX6 locus in glaucoma was initially discovered by a GWAS for VCDR, and subse-
quent GWAS for POAG confirmed the association between polymorphisms in this locus with glaucoma onset9, 33, 34. 
Number 2,306
Age (years) 57.6 ± 13.6
Sex (male/female) 717/1589
IOP (mmHg)† 14.55 ± 3.00
Axial length (mm)† 23.78 ± 1.04
Central corneal thickness (μm)† 543.3 ± 28.6
cpRNFLT (μm)†
 Global 101.6 ± 12.0
 Temporal 76.3 ± 13.9
 Superior 122.4 ± 20.0
 Nasal 75.5 ± 14.3
 Inferior 132.1 ± 20.8
Table 1. Demographics of study participants. Data represent the mean ± SD. IOP, intraocular pressure, 
cpRNFLT, circumpapillary retinal nerve fibre layer thickness. †Data were acquired from the right eye.
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This is the only locus where an association with cpRNFLT has been established30–32. In this study, our detailed 
analysis further specified the cpRNFL region of association, and revealed that SIX1/SIX6 affects cpRNFL thinning 
at 281.3–303.8° among the inferior region, which may have clinical and biological relevance since retinal nerve 
fibre layer defects also occur in this region. In addition, according to the Garway-Heath map27, RNFL thinning 
of this region would lead to upper mid-peripheral VFD and so-called early upper nasal step35. Because VFD in 
this region typically results from early-stage glaucoma, SIX1/SIX6 could be associated with initial changes in 
GON; however, optic fissure closures—known as colobomas—also present in this area. While eyes with apparent 
colobomas were excluded from our analysis, subclinical cases would likely influence the statistical data. Moreover, 
since PAX6 mutations are associated with coloboma formation36 and correlate with SIX6 activation during eye 
development37, SIX1/SIX6 polymorphisms could be involved in the pathophysiology of cpRNFL thinning in 
the inferior region. Although previous reports have not shown a connection between SIX6 SNPs and coloboma 
formation38, 39, further genetic studies with 32-sector cpRNFLT analysis would likely lead to the identification of 
other genes with key roles in glaucomatous VFD development.
Our findings would suggest that we should evaluate genetic associations to cpRNFLT by dividing it into 32 
sectors rather than dividing it into 4 sectors or evaluating cpRNFLT as a whole. Notably, we found a significant 
association between rs33912345 and inferior region cpRNFLT at 292.5–303.8° (P = 0.025 after Bonferroni correc-
tion) in the 32-sectored cpRNFLT analysis, whereas rs33912345 was not significantly associated with the inferior 
region (225–315°) in the 4-sectored analysis (P = 1.0 after Bonferroni correction). Furthermore, all SNPs with 
marginal P-values at 292.5–303.8 and 281.3–292.5° showed an equivalent contribution to cpRNFL thinning to 
that observed with rs33912345. In addition, rs10483727—a RNFLT-susceptible SNP not included in our analy-
sis—showed a significant association with inferior region cpRNFLT at 281.3-303.8° (P = 0.016 and P = 0.016 after 
Bonferroni correction, respectively) in the 32-sector analysis, but not in the 4-sector analysis (225–315°; P = 1.0 
after Bonferroni correction) (Supplementary Tables 1 and 2).
Based on a previous study, cpRNFL thinning at 281.3–303.8° should correspond to mid-peripheral sco-
toma since central VFD is associated with cpRNFL thinning at 311–40° 27. VFD is usually classified as central/
mid-peripheral/peripheral scotoma, superior/inferior altitudinal defect, or temporal/nasal hemianopia that 
shared features of the clinically observed visual field patterns40. The altitudinal boundary is separated at 12° 





Global Temporal Superior Nasal Inferior
Beta P† Beta P† Beta P† Beta P† Beta P†
14 rs140399719_T_C 60940196 SIX1/SIX6 T C −0.76 0.30 −0.69 0.42 1.48 0.22 −1.40 0.11 −2.42 0.056
14 rs144039268_G_T 60940392 SIX1/SIX6 G T −0.09 0.92 0.63 0.50 0.62 0.65 −0.75 0.45 −0.85 0.55
14 rs148908311_T_A 60941172 SIX1/SIX6 T A 0.24 0.80 −1.02 0.35 2.43 0.12 0.24 0.84 −0.68 0.68
14 rs10138913_C_T 60943106 SIX1/SIX6 C T −0.46 0.18 −0.72 0.065 −0.09 0.87 0.29 0.48 −1.31 0.027
14 rs33912345_A_C 60976537 SIX1/SIX6 A C −0.52 0.18 −1.11 0.013 −0.23 0.71 0.67 0.15 −1.41 0.035
14 rs76172201_T_A 60989902 SIX1/SIX6 T A −0.38 0.65 0.93 0.34 −0.08 0.95 −1.78 0.08 −0.60 0.68
14 rs17097602_T_C 60997130 SIX1/SIX6 T C 0.40 0.23 0.45 0.24 0.21 0.70 −0.11 0.79 1.03 0.073
14 rs1955691_G_A 61004128 SIX1/SIX6 G A 0.03 0.95 0.37 0.47 −0.27 0.71 −0.32 0.55 0.34 0.66
14 rs1010053_A_G 61005625 SIX1/SIX6 A G −0.33 0.31 −0.50 0.18 −0.19 0.73 0.41 0.30 −1.06 0.061
14 rs12587483_A_G 61021885 SIX1/SIX6 A G 0.38 0.26 0.35 0.37 0.08 0.88 −0.26 0.53 1.34 0.022
14 rs10133871_A_C 61063771 SIX1/SIX6 A C 0.16 0.67 0.52 0.24 0.21 0.74 −0.06 0.90 −0.02 0.98
14 rs77636526_A_G 61077496 SIX1/SIX6 A G −2.25 0.046 −2.59 0.046 −0.88 0.63 −2.85 0.036 −2.67 0.17
14 rs79319089_A_T 61080521 SIX1/SIX6 A T −0.52 0.50 −0.65 0.47 0.20 0.88 −0.20 0.83 −1.43 0.28
14 rs75320987_C_T 61085911 SIX1/SIX6 C T 0.82 0.15 0.70 0.28 −0.02 0.98 1.06 0.12 1.52 0.12
14 rs2057136_T_A 61106019 SIX1/SIX6 T A 0.29 0.48 0.31 0.52 0.09 0.90 −0.12 0.80 0.90 0.21
14 rs117183588_T_A 61120441 SIX1/SIX6 T A −0.74 0.35 −1.02 0.26 0.62 0.64 −1.50 0.12 −1.06 0.44
14 rs7153648_C_G 61122526 SIX1/SIX6 C G 0.20 0.61 0.44 0.32 0.14 0.83 −0.43 0.36 0.65 0.34
14 rs73309474_C_A 61124161 SIX1/SIX6 C A −1.06 0.21 −1.76 0.070 −0.11 0.94 −1.15 0.26 −1.20 0.41
14 rs143331462_T_C 61124545 SIX1/SIX6 T C 0.03 0.96 0.99 0.22 0.80 0.49 −0.82 0.33 −0.83 0.50
14 rs7143029_T_C 61127916 SIX1/SIX6 T C 0.45 0.22 1.04 0.013 0.34 0.57 −0.28 0.52 0.71 0.26
14 rs12147345_C_T 61140406 SIX1/SIX6 C T 0.48 0.19 1.08 0.010 0.42 0.49 −0.30 0.50 0.73 0.25
14 rs12147346_C_T 61140408 SIX1/SIX6 C T 0.39 0.27 0.81 0.047 0.42 0.47 −0.32 0.46 0.66 0.28
14 rs10137383_T_A 61140517 SIX1/SIX6 T A −0.29 0.54 −0.81 0.13 −0.06 0.94 −0.09 0.88 −0.21 0.80
14 rs12589826_A_G 61143058 SIX1/SIX6 A G 0.42 0.23 0.88 0.031 0.49 0.40 −0.31 0.46 0.64 0.29
14 rs2351179_C_T 61157015 SIX1/SIX6 C T −0.25 0.44 0.05 0.90 0.11 0.83 −0.48 0.23 −0.70 0.22
14 rs61991690_C_T 61160190 SIX1/SIX6 C T 0.42 0.36 0.27 0.60 0.29 0.70 0.20 0.72 0.91 0.25
Table 2. Associations of a SIX1/SIX6 locus and circumpapillary retinal nerve fibre layer thickness including 4 
sectors. CHR, chromosome; SNP, single nucleotide polymorphism; BP, base pair. *Positions and alleles are given 
relative to the positive strand of NCBI build 37 of the human genome. †Linear regression analyses were applied 
assuming additive effect of the per minor allele variant, adjusted for age and sex. Significant (P < 4.8 × 10−4) or 
suggestive (P < 0.0125) associations are shown in bold.
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P* P* P* P* P* P* P* P* P* P* P* P* P* P* P* P*
rs140399719 0.11 0.33 0.14 0.018 0.074 0.51 0.24 0.038 0.016 0.026 0.12 0.80 0.17 0.25 0.33 0.99
rs144039268 0.99 0.87 0.79 0.54 0.33 0.17 0.37 0.62 0.64 0.79 0.26 0.12 0.12 0.29 0.63 0.71
rs148908311 0.31 0.10 0.13 0.22 0.29 0.64 0.050 0.0011 0.022 0.57 0.81 0.29 0.17 0.22 0.68 0.72
rs10138913 0.12 0.060 0.15 0.21 0.45 0.21 0.79 0.058 0.057 0.76 0.12 0.19 0.34 0.68 0.096 0.012
rs33912345 0.14 0.067 0.08 0.054 0.089 0.026 0.57 0.050 0.039 0.54 0.25 0.84 0.70 0.087 0.011 0.0030
rs76172201 0.63 0.46 0.51 0.55 0.30 0.34 0.83 0.46 0.23 0.93 0.94 0.44 0.20 0.23 0.075 0.10
rs17097602 0.19 0.26 0.62 0.80 0.81 0.42 0.43 0.51 0.50 0.80 0.17 0.44 0.60 0.70 0.34 0.14
rs1955691 0.77 0.33 0.25 0.20 0.18 0.54 0.48 0.077 0.08 0.99 0.88 0.53 0.67 0.88 0.31 0.16
rs1010053 0.38 0.57 0.81 0.65 0.74 0.23 0.49 0.69 0.69 0.60 0.56 0.51 0.26 0.072 0.078 0.18
rs12587483 0.27 0.42 0.97 0.91 0.62 0.58 0.60 0.52 0.59 0.73 0.27 0.74 0.96 0.37 0.19 0.16
rs10133871 0.54 0.17 0.084 0.081 0.10 0.35 0.97 0.22 0.16 0.83 0.43 0.18 0.26 0.62 0.68 0.18
rs77636526 0.02 0.064 0.20 0.67 0.88 0.98 0.28 0.78 0.017 0.19 0.98 0.74 0.44 0.07 0.016 0.018
rs79319089 0.38 0.43 0.72 0.96 0.91 0.51 0.23 0.80 0.24 0.60 0.73 0.70 0.98 0.84 0.77 0.96
rs75320987 0.35 0.15 0.12 0.16 0.32 0.82 0.18 0.23 0.87 0.58 0.83 0.23 0.042 0.058 0.29 0.82
rs2057136 0.88 0.39 0.32 0.20 0.13 0.26 0.62 0.21 0.31 0.93 0.84 0.29 0.26 0.78 0.33 0.075
rs117183588 0.024 0.069 0.21 0.65 0.65 0.37 0.32 0.04 0.41 0.58 0.96 0.35 0.08 0.044 0.13 0.59
rs7153648 0.73 0.36 0.33 0.24 0.32 0.83 0.78 0.66 0.74 0.39 0.76 0.93 0.83 0.78 0.14 0.036
rs73309474 0.0098 0.04 0.07 0.18 0.31 0.17 0.58 0.11 0.86 0.89 0.98 0.59 0.28 0.13 0.16 0.45
rs143331462 0.96 0.81 0.35 0.16 0.15 0.31 0.49 0.52 0.38 0.64 0.29 0.34 0.38 0.69 0.71 0.63
rs7143029 0.087 0.036 0.020 0.030 0.044 0.11 0.76 0.58 0.80 0.56 0.68 0.73 0.86 0.87 0.50 0.16
rs12147345 0.070 0.029 0.018 0.023 0.034 0.11 0.75 0.67 0.88 0.48 0.77 0.79 0.86 0.89 0.45 0.14
rs12147346 0.34 0.11 0.070 0.073 0.082 0.27 0.67 0.85 0.94 0.44 0.80 0.67 0.78 0.96 0.39 0.18
rs10137383 0.21 0.14 0.085 0.20 0.19 0.33 0.56 0.55 0.88 0.74 0.48 0.59 0.62 0.81 0.52 0.98
rs12589826 0.28 0.090 0.055 0.056 0.074 0.27 0.60 0.73 0.81 0.36 0.84 0.68 0.79 0.98 0.39 0.18
rs2351179 0.50 0.97 0.96 0.76 0.82 0.95 0.94 0.55 0.34 0.50 0.45 0.42 0.44 0.60 0.28 0.20






























P* P* P* P* P* P* P* P* P* P* P* P* P* P* P* P*
rs140399719 0.96 0.14 0.023 0.031 0.14 0.44 0.85 0.41 0.015 0.0031 0.18 0.99 0.38 0.12 0.89 0.13
rs144039268 0.82 0.58 0.65 0.67 0.45 0.64 0.64 0.26 0.23 0.56 0.68 0.33 0.26 0.28 0.41 0.74
rs148908311 0.82 0.60 0.24 0.21 0.39 0.99 0.49 0.31 0.94 0.28 0.20 0.48 0.80 0.95 0.98 0.66
rs10138913 0.025 0.37 0.86 0.47 0.54 0.94 0.70 0.60 0.018 2.9 × 10−4 0.0035 0.14 0.10 0.088 0.081 0.20
rs33912345 0.019 0.64 0.55 0.79 0.77 0.43 0.23 0.61 0.07 8.1 × 10−5 3.0 × 10−5 0.0027 0.0027 0.012 0.031 0.14
rs76172201 0.10 0.20 0.17 0.29 0.44 0.70 0.72 0.78 0.65 0.73 0.99 0.81 0.52 0.27 0.15 0.22
rs17097602 0.47 0.98 0.77 0.63 0.50 0.85 0.91 0.46 0.034 0.0071 0.069 0.36 0.20 0.20 0.16 0.16
rs1955691 0.045 0.25 1.00 0.67 0.89 0.66 0.71 0.78 0.74 0.25 0.21 0.60 0.83 0.79 0.83 0.79
rs1010053 0.77 0.63 0.66 0.72 0.71 0.63 0.71 0.99 0.082 0.0016 0.0020 0.021 0.023 0.078 0.15 0.18
rs12587483 0.56 0.96 0.92 0.91 0.67 0.93 0.77 0.32 0.010 5.0 × 10−4 0.014 0.26 0.24 0.27 0.23 0.17
rs10133871 0.05 0.32 0.88 0.50 0.96 0.77 0.46 0.67 0.86 0.70 0.68 0.80 0.64 0.55 0.59 0.98
rs77636526 0.12 0.18 0.16 0.10 0.02 0.070 0.41 0.70 0.87 0.93 0.34 0.048 0.043 0.038 0.023 0.029
rs79319089 0.99 0.69 0.52 0.36 0.24 0.45 0.31 0.82 0.92 0.33 0.28 0.56 0.79 0.37 0.19 0.21
rs75320987 0.37 0.94 0.084 0.03 0.18 0.62 0.82 0.85 0.38 0.047 0.044 0.27 0.58 0.61 0.73 0.87
rs2057136 0.016 0.18 0.65 0.21 0.40 0.86 1.00 0.72 0.20 0.036 0.14 0.79 0.86 0.71 0.84 0.66
rs117183588 0.41 0.18 0.36 0.62 0.27 0.49 0.78 0.85 0.58 0.34 0.46 0.48 0.74 0.96 0.51 0.074
rs7153648 0.0029 0.067 0.85 0.37 0.96 0.56 1.00 0.72 0.45 0.13 0.066 0.45 0.54 0.28 0.29 0.90
rs73309474 0.42 0.36 0.77 0.87 0.46 0.62 0.86 0.96 0.74 0.55 0.30 0.15 0.28 0.59 0.23 0.034
rs143331462 0.65 0.56 0.24 0.004 0.0084 0.04 0.029 0.061 0.67 0.27 0.062 0.13 0.069 0.13 0.38 0.80
rs7143029 0.070 0.51 0.96 0.80 0.31 0.23 0.34 0.61 0.45 0.025 0.0013 0.013 0.029 0.033 0.036 0.13
rs12147345 0.070 0.51 0.95 0.78 0.30 0.20 0.32 0.59 0.43 0.019 9.1 × 10−4 0.010 0.024 0.028 0.030 0.11
rs12147346 0.072 0.42 0.92 0.79 0.30 0.29 0.56 0.75 0.51 0.033 0.0036 0.035 0.051 0.038 0.089 0.44
rs10137383 0.93 0.52 0.55 0.82 0.47 0.58 0.22 0.43 0.61 0.44 0.14 0.16 0.30 0.40 0.23 0.21
rs12589826 0.070 0.44 0.93 0.75 0.27 0.30 0.62 0.73 0.55 0.039 0.0042 0.032 0.036 0.022 0.057 0.36
rs2351179 0.094 0.37 0.61 0.26 0.051 0.10 0.17 0.18 0.49 0.51 0.99 0.55 0.37 0.28 0.74 0.32
rs61991690 0.41 0.90 0.76 0.95 0.49 0.50 0.77 0.80 0.53 0.16 0.21 0.34 0.36 0.42 0.35 0.28
Table 3. Associations of SIX1/SIX6 locus polymorphisms and circumpapillary retinal nerve fibre layer 
thickness in 32 sectors. SNP, single nucleotide polymorphism; RNFL, retinal nerve fibre layer. RNFL01–32 starts 
from the temporal region at 0–11.25° and at 11.25° (=360°/32 sectors) interval (clockwise direction). *Linear 
regression analyses were applied assuming additive effect of the per minor allele variant, adjusted for age and 
sex. Significant (P < 6.0 × 10−5) or suggestive (<1.6 × 10−3) associations are shown in bold.
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around optic nerve head (ONH)41; thus, cpRNFL should be evaluated at 12° interval or less (at least 30 sectors) 
to fully evaluate its correspondence to VFD patterns. To our knowledge, this is the first study evaluating the 
applicability of a region-based approach for GON analysis by examining the genetic contributions of glaucoma 
susceptibility genes with regional cpRNFLT. Therefore, genetic studies using 32-sectored cpRNFLT might reveal 
further associations to clinically important glaucoma phenotypes.
To date, three studies have reported significant associations of SIX1/SIX6 polymorphisms to cpRNFL thinning 
in the upper and lower sectors—but not the nasal and temporal sectors—in 30 POAG cases32, 1,243 population 
controls31, and 231 other participants consisting of 20% normal, 44% of suspected glaucoma, and 36% confirmed 
glaucoma cases30. In contrast, our analyses used 2,306 population controls and showed that rs33912345 had the 
strongest association with cpRNFLT at 292.5–303.8° and a marginal association at 78.8–90.0°. RNFL thinning at 
281.3–303.8° would lead to upper mid-peripheral VFDs that could lead to an early upper nasal step27, 35. However, 
further genetic studies on visual field testing are necessary to confirm whether the SIX1/SIX6 locus would be an 
appropriate locus to determine the genetic factors underlying GON in the upper visual fields.
There are several limitations to this study. First, the VFD data was not obtained in our cohort. As the clinical 
importance of VFD has been widely accepted in GON studies, further confirmation analyses on VFD are needed. 
Nevertheless, we believe that cpRNFLT is an objective value with high reliability and repeatability and can facil-
itate the identification of hidden genetic associations for VFD. Second, only data from the right eye of subjects 
were analysed due to the time constraints placed on OCT acquisition; however, because both eyes are equally 
affected by genotype, analyses on the left eyes should yield similar findings. Third, the number of participants 
analysed was rather small compared to the large sample size of the Nagahama cohort. This is mainly because only 
subjects with genome-wide SNP data and an axial length <26 mm were included in the study. A larger sample 
analysis might further elucidate its associations to other regions. Fourth, population-based study methods are 
best evaluated with disease-free subjects. Despite the known association between SIX1/SIX6 SNPs and glaucoma 
development, these patients were not specifically excluded from the study population since we did not perform 
visual field testing or slit lamp biomicroscopy required for this diagnosis. Thus, a subsequent study of only healthy 
subjects will be necessary to confirm the clinical impact of our findings. Lastly, an optimization of sector number 
may be beneficial in future cpRNFLT studies and it is possible that wider sectors would be sufficient to yield the 
same result, whereas a finer sector analysis might be able to find other associations.
In conclusion, we confirmed that rs33912345 and rs10483727—the only known cpRNFLT susceptibility 
SNPs—showed the strongest association with cpRNFLT of those within the SIX1/SIX6 locus. Notably, only 
the 32-sector cpRNFLT analysis was capable of detecting the significant associations these SNPs with inferior 
cpRNFL thinning at 292.5–303.8° and 281.3–303.8°, respectively, as the results of 4-sector cpRNFLT analysis 
were insignificant. Collectively, this suggests that fine regional association analyses are a more effective strategy 
to assess glaucoma endophenotype in genomic studies and may facilitate the identification of novel genetic asso-
ciations in disease pathogenesis.
Methods
Ethical considerations. Written informed consent was obtained from all participants. Study proce-
dures adhered to the tenets of the Declaration of Helsinki and were approved by the ethics committee of Kyoto 
University Graduate School of Medicine and the Nagahama Municipal Review Board.
Study participants. The study population consisted of healthy Japanese volunteers enrolled in the 
Nagahama Prospective Cohort for Comprehensive Human Bioscience (the Nagahama Study). Participants were 
recruited between 2008 and 2010 from the general population of Nagahama City, a rural city of 125,000 inhab-
itants located in central Japan. Community residents from 30–74 years of age, living independently and without 
physical impairment or dysfunction were eligible. Of the 9,804 included participants, nine withdrew consent to 
participate, and 26 were excluded because genetic analysis showed an ethnic background other than Japanese. 
Participants were offered a follow-up assessment 5 years after the baseline evaluation, and 8,294 of the original 
9,769 cohort members participated (84.9%).
In the present study, we used a dataset of the follow-up measurement. Study subjects consisted of 2,807 indi-
viduals with genome-wide SNP genotyping, axial length, phakic status, and OCT data available by April 2016. 
Other exclusion criteria included prior intraocular surgery (except for cataract surgery), high myopia (axial 
length ≥26 mm), and presence of other ocular diseases affecting retinal nerve fibre layer thickness based on fun-
dus photography—such as optic atrophy, anterior ischemic optic neuropathy, optic disc coloboma, retinal vein 
occlusion, proliferative or severe non-proliferative diabetic retinopathy, retinitis pigmentosa, and other optic neu-
ropathies. Subjects outside of the Japanese ethnic cluster or with poor quality cpRNFL images, which could result 
from cataracts or small pupils, were also excluded. Glaucomatous status did not serve as exclusion criteria since 
visual field information was unavailable at the time of analysis. Ultimately, a total of 2,306 subjects with a ≤ 0.9 
sample call rate and estimated relatedness (PI-HAT) >0.35 were included in the study population
All subjects were assessed by standardized ophthalmic examination, including an objective determination 
of the refractive error and corneal curvature (Autorefractor ARK-530; Nidek, Gamagori, Aichi, Japan), fundus 
imaging (CR-DG10; Canon, Tokyo, Japan), and axial length measurements by partial coherence interferometry 
(IOL Master; Carl Zeiss Meditec, Inc., Dublin, California, USA). The cpRNFL in the right eye was imaged by 
spectral-domain optical coherence tomography (SD-OCT) (RS-3000 advanced; Nidek, Gamagori, Aichi, Japan).
Circumpapillary retinal nerve fibre layer thickness. The RS-3000 advanced OCT (Nidek) was used to 
obtain circular B-scans 11.5° in diameter (3.45 mm in the Gullstrand’s eye) centred on the optic disc, i.e., a cir-
cumpapillary scan. Each B-scan was obtained by averaging 50 images in “Regular mode” to reduce speckle noise. 
The cpRNFL thickness was defined as the distance between the inner border of the internal limiting membrane 
www.nature.com/scientificreports/
6Scientific RepoRts | 7: 4393  | DOI:10.1038/s41598-017-02299-7
(ILM) and the outer border of the RNFL in B-scan images, measured automatically with built-in software, and 
then manually corrected for all images. We excluded eyes with extensive peripapillary atrophy (affecting cpRNFL 
scans), RNFL schisis, peripapillary epiretinal membrane, or thickened posterior vitreous membrane that affected 
segmentation, and low quality or other RNFL segmentation errors.
RNFL thickness was measured at 1,024 points along the 360° OCT circle scan, which were subsequently sec-
tioned into 4 or 32 sectors (Fig. 1). Data for each sector were averaged and the associations between the SIX1/SIX6 
SNPs and mean cpRNFLT in each region were analysed.
Genotyping and imputation. DNA samples were prepared and genotyped as described previ-
ously42. Briefly, 3,712 baseline samples were genotyped using at least one of the three genotyping platforms, 
HumanHap610K Quad Arrays, HumanOmni2.5 M Arrays, or HumanExome Arrays (Illumina, Inc., San Diego, 
CA). To ensure high-quality genotype data, a series of quality control (QC) filters, including sample success 
rate (>95%), individual call rate (>99%), minor allele frequency (MAF) cut-off (>0.01), Hardy-Weinberg equi-
librium p-values (>1 × 10−6), and estimated relatedness (PI-HAT < 0.35) were applied to the data from each 
platform. In addition, seven ancestry outliers were identified by principal component analysis with the HapMap 
Phase 2 release 28 with the Japanese in Tokyo, Japan (JPT) reference dataset using EIGENSTRAT ver. 2.0. QC in 
PLINK39, 43 (ver.1.07; available at http://pngu.mgh.harvard.edu/~purcell/plink/). As a result, 3,267 baseline and 
2,807 follow-up samples passed the QC filters. SNP genotype imputation was performed for the Japanese sam-
ples using MaCH44. Genotypes of 89 JPT samples from the 1000 Genomes Project (May 2011 release) were used 
as reference sequences. Imputed SNPs with an R-squared value less than 0.5 were excluded from the following 
association analyses.
Our dataset contained 488 SNPs within ±50 kb of the SIX1/SIX6 locus (chr14: 60925938–61166155; 
NCBI build 37). The Tagger program in Haploview45 was used to identify 26 tagging-SNPs encompassing the 
242 known SNPs with an MAF > 0.05 (mean R-sq = 0.962). Since rs33912345 was previously reported as a 
cpRNFLT-susceptible SNP, it was selected as a tagging SNP for a positive control. The location of these 26 SNPs 
within the SIX1/SIX6 locus and a linkage disequilibrium plot of this genetic region are shown in Fig. 2.
Figure 1. Illustration of the 32 sectors along the RS-3000 advanced (Nidek) optical coherence tomographic 
(OCT) circular image used for circumpapillary retinal nerve fibre layer thicknesses (cpRNFLT) analysis. (A,B) 
Circular B-scans 11.5° in diameter (3.45 mm in the Gullstrand’s eye) centred on the optic disc were obtained 
from the right eye of each participant. (C) cpRNFLT was measured at 1,024 points along the 360° OCT circle 
scan and divided into 4 or 32 sectors.
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Statistical analysis. Linear regression analyses were performed to determine the associations between 
regional cpRNFLT and the 26 SNP genotypes assuming additive regression models for a per-minor-allele with 
an adjustment for age, sex, and axial length. We evaluated regional cpRNFLT associations using 4 divided sectors 
and finer 32 sectors with Bonferroni corrections. P values < 6.0 × 10−5 (0.05/26 SNPs/32 sectors) and <4.8 × 10−4 
(0.05/26 SNPs/4 sectors) were considered statistically significant for cpRNFL in the 32-sector and 4-sectors analy-
ses, respectively, whereas P-values < 0.0016 (0.05/32 sectors) and <0.0125 (0.05/4 sectors) were considered mar-
ginally significant, respectively.
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